| 1 |
Aharon A, Dangot A, Kinaani F, Zavaro M, Bannon L, Bar-Lev T, Keren-Politansky A, Avivi I, Jacob G. Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity. Int J Mol Sci 2023;24:5918. [PMID: 36982991 DOI: 10.3390/ijms24065918] [Reference Citation Analysis]
|
| 2 |
Thakur A. Shedding Lights on the Extracellular Vesicles as Functional Mediator and Therapeutic Decoy for COVID-19. Life (Basel) 2023;13:840. [PMID: 36983995 DOI: 10.3390/life13030840] [Reference Citation Analysis]
|
| 3 |
Li Z, Mu S, Tian Y, Shi J, Lan Y, Guan J, Zhao K, Gao F, He W. Porcine Hemagglutinating Encephalomyelitis Virus Co-Opts Multivesicular-Derived Exosomes for Transmission. mBio 2023;14:e0305422. [PMID: 36541757 DOI: 10.1128/mbio.03054-22] [Reference Citation Analysis]
|
| 4 |
Askari H, Rabiei F, Lohrasbi F, Ghadir S, Ghasemi-kasman M. The Latest Cellular and Molecular Mechanisms of COVID-19 on Non-Lung Organs. Brain Sciences 2023;13:415. [DOI: 10.3390/brainsci13030415] [Reference Citation Analysis]
|
| 5 |
Pordanjani PM, Bolhassani A, Milani A, Pouriayevali MH. Extracellular vesicles in vaccine development and therapeutic approaches for viral diseases. Process Biochemistry 2023. [DOI: 10.1016/j.procbio.2023.02.028] [Reference Citation Analysis]
|
| 6 |
Mardi N, Haiaty S, Rahbarghazi R, Mobarak H, Milani M, Zarebkohan A, Nouri M. Exosomal transmission of viruses, a two-edged biological sword. Cell Commun Signal 2023;21:19. [PMID: 36691072 DOI: 10.1186/s12964-022-01037-5] [Reference Citation Analysis]
|
| 7 |
Moulin C, Crupi MJF, Ilkow CS, Bell JC, Boulton S. Extracellular Vesicles and Viruses: Two Intertwined Entities. Int J Mol Sci 2023;24. [PMID: 36674550 DOI: 10.3390/ijms24021036] [Reference Citation Analysis]
|
| 8 |
Motallebnezhad M, Omraninava M, Esmaeili Gouvarchin Ghaleh H, Jonaidi-Jafari N, Hazrati A, Malekpour K, Bagheri Y, Izadi M, Ahmadi M. Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19. Pathol Res Pract 2023;241:154280. [PMID: 36580795 DOI: 10.1016/j.prp.2022.154280] [Reference Citation Analysis]
|
| 9 |
Kongsomros S, Pongsakul N, Panachan J, Khowawisetsut L, Somkird J, Sangma C, Kanjanapruthipong T, Wongtrakoongate P, Chairoungdua A, Pattanapanyasat K, Newburg DS, Morrow AL, Hongeng S, Thitithanyanont A, Chutipongtanate S. Comparison of viral inactivation methods on the characteristics of extracellular vesicles from SARS-CoV-2 infected human lung epithelial cells. J Extracell Vesicles 2022;11:e12291. [PMID: 36468940 DOI: 10.1002/jev2.12291] [Reference Citation Analysis]
|
| 10 |
Shaymardanov AM, Antonova OA, Sokol AD, Deinichenko KA, Kazakova PG, Milovanov MM, Zakubansky AV, Akinshina AI, Tsypkina AV, Romanova SV, Muhin VE, Mitrofanov SI, Yudin VS, Yudin SM, Makhotenko AV, Keskinov AA, Kraevoy SA, Snigir EA, Svetlichnyy DV, Skvortsova VI. Single-Cell Gene Expression Analysis Revealed Immune Cell Signatures of Delta COVID-19. Cells 2022;11:2950. [DOI: 10.3390/cells11192950] [Reference Citation Analysis]
|
| 11 |
Mysiris DS, Vavougios GD, Karamichali E, Papoutsopoulou S, Stavrou VT, Papayianni E, Boutlas S, Mavridis T, Foka P, Zarogiannis SG, Gourgoulianis K, Xiromerisiou G. Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis. IJMS 2022;23:9739. [DOI: 10.3390/ijms23179739] [Reference Citation Analysis]
|
| 12 |
Alahdal M, Elkord E. Promising use of immune cell-derived exosomes in the treatment of SARS-CoV-2 infections. Clin Transl Med 2022;12:e1026. [PMID: 35988156 DOI: 10.1002/ctm2.1026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Kuklina EM. T Lymphocytes as Targets for SARS-CoV-2. Biochemistry Moscow 2022;87:566-576. [DOI: 10.1134/s0006297922060086] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 14 |
Rezabakhsh A, Mahdipour M, Nourazarian A, Habibollahi P, Sokullu E, Avci ÇB, Rahbarghazi R. Application of exosomes for the alleviation of COVID-19-related pathologies. Cell Biochem Funct 2022. [PMID: 35647674 DOI: 10.1002/cbf.3720] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 15 |
Bortot B, Romani A, Ricci G, Biffi S. Exploiting Extracellular Vesicles Strategies to Modulate Cell Death and Inflammation in COVID-19. Front Pharmacol 2022;13:877422. [DOI: 10.3389/fphar.2022.877422] [Reference Citation Analysis]
|
| 16 |
Happel C, Peñalber-johnstone C, Tagle DA. Pivoting Novel Exosome-Based Technologies for the Detection of SARS-CoV-2. Viruses 2022;14:1083. [DOI: 10.3390/v14051083] [Reference Citation Analysis]
|
| 17 |
Cao H, Abd Aziz NH, Xavier JR, Shafiee MN, Kalok A, Jee B, Salker MS, Singh Y. Dysregulated Exosomes Result in Suppression of the Immune Response of Pregnant COVID-19 Convalescent Women. Front Mol Biosci 2022;9:869192. [DOI: 10.3389/fmolb.2022.869192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Chen J, Liu R, Huang T, Sun H, Jiang H. Adipose stem cells-released extracellular vesicles as a next-generation cargo delivery vehicles: a survey of minimal information implementation, mass production and functional modification. Stem Cell Res Ther 2022;13:182. [PMID: 35505389 DOI: 10.1186/s13287-022-02849-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Zhang Y, Guo W, Bi M, Liu W, Zhou L, Liu H, Yan F, Guan L, Zhang J, Xu J, Cabello-verrugio C. Migrasomes: From Biogenesis, Release, Uptake, Rupture to Homeostasis and Diseases. Oxidative Medicine and Cellular Longevity 2022;2022:1-13. [DOI: 10.1155/2022/4525778] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 20 |
Krishnan A, Muthusamy S, Fernandez FB, Kasoju N. Mesenchymal Stem Cell-Derived Extracellular Vesicles in the Management of COVID19-Associated Lung Injury: A Review on Publications, Clinical Trials and Patent Landscape. Tissue Eng Regen Med 2022. [PMID: 35384633 DOI: 10.1007/s13770-022-00441-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Alphandéry E. Nano dimensions/adjuvants in COVID-19 vaccines. J Mater Chem B 2022. [PMID: 35166754 DOI: 10.1039/d1tb02408f] [Reference Citation Analysis]
|
| 22 |
Phua VJX, Yang C, Xia B, Yan SX, Liu J, Aw SE, He T, Ng DCE. Nanomaterial Probes for Nuclear Imaging. Nanomaterials 2022;12:582. [DOI: 10.3390/nano12040582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 23 |
Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. Int J Mol Sci 2022;23:1716. [PMID: 35163638 DOI: 10.3390/ijms23031716] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
|
| 24 |
Sayad B, Mohseni Afshar Z, Mansouri F, Salimi M, Miladi R, Rahimi S, Rahimi Z, Shirvani M. Pregnancy, Preeclampsia, and COVID-19: Susceptibility and Mechanisms: A Review Study. Int J Fertil Steril 2022;16:64-9. [PMID: 35639648 DOI: 10.22074/IJFS.2022.539768.1194] [Reference Citation Analysis]
|
| 25 |
Chen C, Wang J, Sun M, Li J, Wang HD. Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery. Biomed Pharmacother 2021;145:112416. [PMID: 34781147 DOI: 10.1016/j.biopha.2021.112416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 26 |
Kongsomros S, Suksatu A, Kanjanasirirat P, Manopwisedjaroen S, Prasongtanakij S, Jearawuttanakul K, Borwornpinyo S, Hongeng S, Thitithanyanont A, Chutipongtanate S. Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir. Biomedicines 2021;9:1230. [PMID: 34572416 DOI: 10.3390/biomedicines9091230] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 27 |
Kato T, Vykoukal JV, Fahrmann JF, Hanash S. Extracellular Vesicles in Lung Cancer: Prospects for Diagnostic and Therapeutic Applications. Cancers (Basel) 2021;13. [PMID: 34572829 DOI: 10.3390/cancers13184604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
